METABOLIC BONE DISEASE INDUCED BY PROSTATE CANCER: RATIONALE FOR THE USE OF BISPHOSPHONATES-Reference-Cited by-同舟云学术

METABOLIC BONE DISEASE INDUCED BY PROSTATE CANCER: RATIONALE FOR THE USE OF BISPHOSPHONATES

Published:2001-12 Issue:6 Volume:166 Page:2023-2031
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BERRUTI ALFREDO¹,DOGLIOTTI LUIGI¹,TUCCI MARCELLO¹,TARABUZZI ROBERTO¹,FONTANA DARIO¹,ANGELI ALBERTO¹

Affiliation:

1. From the Department of Clinical Science and Biology, Università degli Studi di Torino, Torino and Departments of Medical Oncology, Internal Medicine and Urology, Azienda Ospedaliera San Luigi di Orbassano, Orbassano, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference120 articles.

1. Bone Metastases: Diagnosis and Treatment;Rubens,1991

2. Spread of prostatic cancer to bone;Jacobs;Urology,1983

3. The anatomy and pathway of skeletal metastases;Galasko,1981

4. Prostate cancer. Primary hormonal treatment;Denis;Cancer, suppl.,1993

5. Management of hormone refractory prostate cancer: current standards and future prospects;Oh;J Urol,1998

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formation of pre-metastatic bone niche in prostate cancer and regulation of traditional chinese medicine;Frontiers in Pharmacology;2022-08-17

2. GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy—study protocol;BMJ Open;2019-08

3. Zoledronic acid for the treatment of prostate cancer;Expert Opinion on Pharmacotherapy;2019-02-07

4. Low dose effect of bisphosphonates on hMSCs osteogenic response to titanium surface in vitro;Bone Reports;2017-06

5. Do Patients After Chondrosarcoma Treatment Have Age-appropriate Bone Mineral Density in the Long Term?;Clinical Orthopaedics & Related Research;2016-06